Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,119 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Brazilian Reality in the Diagnosis and Treatment of Diffuse Large B Cell Lymphoma - BRA-DLBCL

NCT05958134

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Research Site Belo Horizonte, Brazil

Research Site Recife, Brazil

Research Site Salvador, Brazil

Research Site São Paulo, Brazil

View Trial Details

Completed

Supporting Parents to Choose Wisely

NCT06005337

Conditions: Acute Asthma, Acute Otitis Media, Bronchial Diseases, +31 more
Locations: University of Alberta Edmonton, Alberta, Canada

View Trial Details

Completed

MEOI and HRQoL in CLL Patients Treated With BTKis

NCT04938141

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Research Site Fountain Valley, California, United States

Research Site Redlands, California, United States

Research Site Boca Raton, Florida, United States

Research Site Fort Lauderdale, Florida, United States

View all 16 locations

View Trial Details

Completed

A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma as Compared With Standard of Care Therapies

NCT06592222

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Pfizer New York, United States

View Trial Details

Completed

Multi-centers, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Donor-Derived CD7 CAR T Cells in Subjects With Relapsed or Refractory T-cell Leukemia/Lymphoma

NCT04689659

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +16 more
Locations: Beijing Boren Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Study of Anti-CD22 CAR-T Cells Treating Leukemia Children

NCT04340167

Conditions: Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Hematologic Diseases, +11 more
Locations: Beijing Boren Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Phase II Study of Anti-CD19 CAR-T Cells Treating Leukemia Children

NCT04325841

Conditions: Acute Lymphoblastic Leukemia, Pediatric, Acute Lymphoblastic Leukemia, in Relapse, Hematologic Diseases, +11 more
Locations: Beijing Boren Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Janus Kinase Inhibition in Sarcoidosis

NCT05696795

Conditions: Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +4 more
Locations: Yale University New Haven, Connecticut, United States

View Trial Details

Completed

Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor

NCT01350245

Conditions: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Anemia, +35 more
Locations: Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Palbociclib and Dexamethasone in Treating Participants With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

NCT03472573

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations: Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions